Cancer risk assessment interpretive software IVD
- Device ID
- 175897
- Status
- DREGIY
- Date Registered
- Dec 17, 2023
- Device Type
- In Vitro Diagnostic Device
- Type
- Class C
- Name
- Proteomedix AG
- Address
- Wagistrasse 23Schlieren, Switzerland
Devices with a matching generic name or device type registered with MHRA
Additional devices registered by the same manufacturer
Cancer risk assessment interpretive software IVD is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 175897. The device is manufactured by Proteomedix AG from Switzerland, classified as In Vitro Diagnostic Device.
This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.